Advanced panel for respiratory tract infection testing
The newly CE marked FilmArray Respiratory Panel 2 plus (RP2plus) tests for 22 pathogens (18 viruses and 4 bacteria) responsible for respiratory tract infections. It advances the existing FilmArray Respiratory Panel (RP) by reducing the assay time from about an hour to less than 45 minutes, improving overall sensitivity, and updating several assays. FilmArray RP2plus also includes 2 additional pathogens: Bordetella parapertussis, one of the causative agents of pertussis or whooping cough, a highly infectious bacterial disease, and Middle East Respiratory Syndrome coronavirus (MERS-CoV). According to the WHO, the recent MERS-CoV outbreak in the Republic of Korea demonstrated a great potential for widespread transmission and severe disruption both to the health system and to society. The MERS-CoV case fatality rate is approximately 36%. Bordetella parapertussis infections represent a significant cause of whooping cough which is oft en missed because of a clinical presentation largely indistinguishable from other viral infections and of lack of reliable diagnostic tests. The FilmArray RP2plus is available for use on the FilmArray 2.0 and FilmArray Torch systems and will be commercially available in the countries that recognize CE marking by mid-June 2017.
Supplier: Biomérieux
Website:
